BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 17609808)

  • 1. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Lien MH; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):764-72. PubMed ID: 20677530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
    McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
    Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of cutaneous T-cell lymphomas].
    Rappersberger K; Ortel B; Forstinger C; Wolff K
    Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current therapy concepts in cutaneous T-cell lymphomas].
    Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
    Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of cutaneous T-cell lymphoma with photopheresis.
    Zic JA
    Dermatol Ther; 2003; 16(4):337-46. PubMed ID: 14686977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous T cell lymphomas: photochemotherapy immunomodulation with analysis of the inflammatory-expansive cellular dynamic.
    Werber-Bandeira L; Herdy AM; Pagani EA; Filgueira AL
    Dermatol Ther; 2014; 27(2):74-8. PubMed ID: 24703262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
    Kofoed K; Schiødt I; Gniadecki R
    Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.